You need to enable JavaScript to run this app.
FDA proposes removing oral phenylephrine from use in nasal decongestants
Regulatory News
Joanne S. Eglovitch
CDER
Compliance
OTC
OTC monograph
Over the counter drugs (OTCs)
Quality Assurance and Control
Regulatory Intelligence/Policy
United States